Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is methylation analysis of SFRP2 , TFPI2 , NDRG4 , and BMP3 promoters suitable for colorectal cancer screening in the Korean population?

1 Jan 2017

Abstract excerpt

Background/Aims: Colorectal cancer (CRC) screening using stool DNA was recently found to yield good detection rates. A multi-target stool DNA test (Cologuard , Exact Sciences), including methylated genes has been recently approved by the U.S. Food and Drug Administration. The aim of this study was to validate these aberrantly methylated genes as stool-based DNA markers for detecting CRC and colorectal advanced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Genetic factors in colorectal cancer
Share to Mechanisms of cancer metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29142517
DOI: 10.5217/ir.2017.15.4.495

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is methylation analysis of SFRP2 , TFPI2 , NDRG4 , and BMP3 promoters suitable for colorectal cancer screening in the Korean population?PMID 29142517Read ↗

DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNASemantic proximity Read ↗

Stool DNA methylation assays in colorectal cancer screeningSemantic proximity Read ↗

Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.Semantic proximity Read ↗

DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancerSemantic proximity Read ↗

Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysisSemantic proximity Read ↗

Evaluating the Clinical Performance of SDC2/NDRG4 Methylation for Colorectal Cancer DetectionSemantic proximity Read ↗

Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesionsSemantic proximity Read ↗

Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancerSemantic proximity Read ↗

Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2 , and PRIMA1 in plasma samplesSemantic proximity Read ↗

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal CancerSemantic proximity Read ↗

Hypermethylation of SFRP2 as a Potential Marker for Stool-Based Detection of Colorectal Cancer and Precancerous LesionsSemantic proximity Read ↗

Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.